Curcumin modulates endothelial permeability and monocyte transendothelial migration by affecting endothelial cell dynamics

Free Radic Biol Med. 2017 Nov:112:109-120. doi: 10.1016/j.freeradbiomed.2017.07.019. Epub 2017 Jul 22.

Abstract

Curcumin is a phenolic compound that exhibits beneficial properties for cardiometabolic health. We previously showed that curcumin reduced the infiltration of immune cells into the vascular wall and prevented atherosclerosis development in mice. This study aimed to investigate the effect of curcumin on monocyte adhesion and transendothelial migration (TEM) and to decipher the underlying mechanisms of these actions. Human umbilical vein endothelial cells (HUVECs) were exposed to curcumin (0.5-1μM) for 3h prior to their activation by Tumor Necrosis Factor alpha (TNF-α). Endothelial permeability, monocyte adhesion and transendothelial migration assays were conducted under static condition and shear stress that mimics blood flow. We further investigated the impact of curcumin on signaling pathways and on the expression of genes using macroarrays. Pre-exposure of endothelial cells to curcumin reduced monocyte adhesion and their transendothelial migration in both static and shear stress conditions. Curcumin also prevented changes in both endothelial permeability and the area of HUVECs when induced by TNF-α. We showed that curcumin modulated the expression of 15 genes involved in the control of cytoskeleton and endothelial junction dynamic. Finally, we showed that curcumin inhibited NF-κB signaling likely through an antagonist interplay with several kinases as suggested by molecular docking analysis. Our findings demonstrate the ability of curcumin to reduce monocyte TEM through a multimodal regulation of the endothelial cell dynamics with a potential benefit on the vascular endothelial function barrier.

Keywords: Curcumin; Endothelial cell; Endothelial permeability; Monocyte adhesion; Transendothelial migration.

MeSH terms

  • Biomechanical Phenomena
  • Cell Adhesion / drug effects
  • Cell Movement / drug effects*
  • Coculture Techniques
  • Curcumin / pharmacology*
  • Cytoskeletal Proteins / genetics
  • Cytoskeletal Proteins / metabolism
  • Diffusion Chambers, Culture
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects*
  • Human Umbilical Vein Endothelial Cells / cytology
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • MAP Kinase Kinase Kinases / antagonists & inhibitors
  • MAP Kinase Kinase Kinases / chemistry
  • MAP Kinase Kinase Kinases / genetics
  • Microarray Analysis
  • Molecular Docking Simulation
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / chemistry
  • NF-kappa B / genetics
  • Permeability / drug effects
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / chemistry
  • Protein Serine-Threonine Kinases / genetics
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / chemistry
  • Proto-Oncogene Proteins c-akt / genetics
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • Rheology
  • Signal Transduction
  • THP-1 Cells
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Cytoskeletal Proteins
  • NF-kappa B
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • Tumor Necrosis Factor-alpha
  • AKT1 protein, human
  • AKT2 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7
  • Curcumin